AbCellera Biologics's total assets for Q1 2025 were $579.23M, a decrease of -57.43% from the previous quarter. ABCL total liabilities were $245.83M for the fiscal quarter, a -19.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.